Belgian Electrical Stock News

ENXTBR:FAGR
ENXTBR:FAGRHealthcare

Assessing Fagron (ENXTBR:FAGR) Valuation After Earnings Beat, Dividend Hike And 2026 Guidance

Why Fagron’s latest earnings matter for shareholders Fagron (ENXTBR:FAGR) has just reported full year 2025 results, held its earnings call, raised its proposed dividend to €0.40 per share, and outlined guidance for 2026 that points to continued organic growth and slightly higher profitability. For you as an investor, that combination of reported numbers, a higher cash payout, and forward looking guidance offers fresh information about how the business is performing today and how management is...
ENXTBR:EXM
ENXTBR:EXMOil and Gas

Exploring 3 Undiscovered Gems in European Markets

As European markets experience volatility amid global economic shifts, the pan-European STOXX Europe 600 Index recently hit a new high but ended the week with only a slight gain of 0.09%. This backdrop of fluctuating investor sentiment and economic expansion in key regions like the eurozone presents an intriguing environment for uncovering lesser-known stocks that might offer unique opportunities. In such conditions, identifying stocks with strong fundamentals and potential resilience to...
ENXTBR:AED
ENXTBR:AEDHealth Care REITs

A Look At Aedifica (ENXTBR:AED) Valuation After Strong Results And Higher Proposed Dividend

Why Aedifica/SA (ENXTBR:AED) is back on income investors’ radar Aedifica/SA (ENXTBR:AED) has drawn fresh attention after confirming a proposed gross dividend of €4.00 per share for May 2026, alongside full year 2025 results showing higher sales, net income and earnings per share. See our latest analysis for Aedifica/SA. The confirmation of the proposed €4.00 dividend and stronger 2025 results come after an 18.45% 90-day share price return and a 36.72% 1-year total shareholder return,...
ENXTBR:CMBT
ENXTBR:CMBTOil and Gas

Cmb.Tech (ENXTBR:CMBT) Valuation Check After US$98.2 Million VLCC Sale Gain

Cmb.Tech (ENXTBR:CMBT) has agreed to sell two VLCCs, Ingrid and Ilma. The transaction is expected to generate an approximate US$98.2 million capital gain recorded in the second quarter of 2026. See our latest analysis for Cmb.Tech. The vessel sale headlines arrive as Cmb.Tech's share price trades at €11.22, with a 30-day share price return of 11.53% and a 90-day share price return of 33.57%. The 1-year total shareholder return of 17.80% sits against a 5-year total shareholder return of...
ENXTBR:BAR
ENXTBR:BARElectronic

Assessing Barco (ENXTBR:BAR) Valuation After Solid Full Year 2025 Earnings Results

Barco (ENXTBR:BAR) has released its full year 2025 results, reporting sales of €963.84 million and net income of €71.56 million. These figures help frame the recent share performance. See our latest analysis for Barco. Despite the solid full year 2025 figures, Barco’s share price has softened, with a 30 day share price return of an 11.79% decline and a 1 year total shareholder return of a 4.9% loss, suggesting momentum has been fading recently. If these results have you thinking about where...
ENXTBR:SOLB
ENXTBR:SOLBChemicals

Is It Time To Reconsider Solvay (ENXTBR:SOLB) After The Recent Share Price Pullback?

If you are trying to work out whether Solvay shares at €27.84 are starting to look attractively priced, you are in the right place. The stock has returned 4.0% over the last 7 days and 2.7% over the past month, while the 1 year return sits at a 9.2% decline, compared with longer term returns of 44.3% over 3 years and 73.9% over 5 years. These moves come against a backdrop where investors have been reassessing Solvay's positioning in the materials sector and its portfolio after previous...
ENXTBR:094426466
ENXTBR:094426466Metals and Mining

Is It Too Late To Reassess SCR-Sibelco (ENXTBR:094426466) After Recent Share Price Weakness?

If you are wondering whether SCR-Sibelco is priced fairly today, you are not alone. The stock often attracts attention from investors trying to work out if they might be overpaying or missing an opportunity. Over the short term, the share price has been mixed, with a 1.3% return over the last 7 days, a 0.8% decline over 30 days, and returns of 12.7% decline year to date and 5.7% decline over the past year, extending to a 10.9% decline over five years. Recent news coverage has mainly focused...
ENXTBR:JEN
ENXTBR:JENMachinery

Undiscovered Gems in Europe Promising Stocks for February 2026

As European markets experience volatility amid global concerns about AI disruption, the pan-European STOXX Europe 600 Index has managed to reach new highs, reflecting a cautiously optimistic sentiment. In this dynamic environment, identifying promising stocks requires a keen understanding of market trends and economic indicators that can reveal potential growth opportunities.
ENXTBR:SIP
ENXTBR:SIPFood

3 European Dividend Stocks To Consider With Up To 6% Yield

As European markets experience volatility amid global concerns over AI disruption, the pan-European STOXX Europe 600 Index managed to hit a new high, ending the week with a slight gain. In such an environment, dividend stocks can offer investors a degree of stability and income potential, making them attractive options for those looking to navigate uncertain market conditions.
ENXTBR:MONT
ENXTBR:MONTIndustrial REITs

Assessing Montea Comm. VA (ENXTBR:MONT) Valuation After Recent Mixed Share Price Performance

Montea Comm. VA overview Montea Comm. VA (ENXTBR:MONT) is back in focus after investors reacted to its recent share performance, with the stock showing mixed returns over the past week, month and past 3 months. The logistics focused real estate group, active across Belgium, the Netherlands, France and Germany, now trades around €74. This has prompted fresh interest in how its long term total returns compare with its current valuation profile. See our latest analysis for Montea Comm...
ENXTBR:AED
ENXTBR:AEDHealth Care REITs

Aedifica (ENXTBR:AED) One Off Gain Lifts Earnings And Tests Bullish Narratives

Aedifica/SA (ENXTBR:AED) has wrapped up FY 2025 with fourth quarter revenue of €90.5 million and basic EPS of €1.06. Trailing 12 month figures show revenue of €369.6 million and EPS of €5.14. The company has reported revenue increasing from €346.5 million to €369.6 million on a trailing 12 month basis, with EPS rising from €4.31 to €5.14 over the same period. Quarterly revenue ranged between €90.2 million and €95.4 million, and EPS between €0.71 and €1.70 across the last six reported...
ENXTBR:UCB
ENXTBR:UCBPharmaceuticals

Assessing UCB (ENXTBR:UCB) Valuation As Amgen’s Uplizna Enters Generalized Myasthenia Gravis

Competitive pressure in generalized myasthenia gravis The European Commission’s approval of Amgen’s Uplizna for generalized myasthenia gravis puts fresh competitive pressure on UCB (ENXTBR:UCB) in a treatment area where it already markets RYSTIGGO and ZILBRYSQ. See our latest analysis for UCB. Against this backdrop of fresh competition in generalized myasthenia gravis, UCB’s share price has climbed to €279.5, with a 90 day share price return of 22.27% and a 1 year total shareholder return of...
ENXTBR:094426466
ENXTBR:094426466Metals and Mining

Assessing SCR-Sibelco (ENXTBR:094426466) Valuation After Recent Mixed Share Price Performance

Recent share performance and current snapshot SCR-Sibelco (ENXTBR:094426466) has been relatively stable in the very short term, with the share price flat over the past day and a modest 1.3% gain over the past week. Over longer periods, the picture is more mixed, with a small decline over the past month, a 3% gain over the past 3 months, and negative returns year to date and over the past year and the past 3 to 5 years. See our latest analysis for SCR-Sibelco. That mix of a 3.03% 90 day share...
ENXTBR:SIP
ENXTBR:SIPFood

Sipef (ENXTBR:SIP) Net Margin At 22% Challenges Bearish Earnings Narratives

Sipef (ENXTBR:SIP) has reported fresh FY 2025 numbers, with first half revenue of US$250.4 million and EPS of US$5.54, set against trailing 12 month revenue of US$570.4 million and EPS of US$12.05 that came with 90.5% earnings growth over the past year. The company has seen revenue move from US$203.1 million and EPS of US$2.41 in 1H 2024 to US$239.3 million and EPS of US$3.91 in 2H 2024, before reaching the latest 1H 2025 levels. This progression gives investors a clearer run rate on both the...
ENXTBR:UMI
ENXTBR:UMIChemicals

Reassessing Umicore (ENXTBR:UMI) After A 103% Share Price Rebound

If you are wondering whether Umicore is still attractively priced after a volatile few years, this article will walk through what the current share price might imply about value. Over the last year, the share price is up 102.8%, even though the 7 day and 30 day returns are 3.2% and 1.8% declines and the 3 year and 5 year returns are 36.6% and 56.1% declines, with the stock most recently closing at €19.05. These moves sit against a backdrop of ongoing attention on Umicore's role in materials...
ENXTBR:ONTEX
ENXTBR:ONTEXPersonal Products

Ontex Group EPS Loss Rekindles Doubts Over Bullish Margin Recovery Narratives

Ontex Group (ENXTBR:ONTEX) has just posted its FY 2025 first half results, with revenue of €880.3 million and a basic EPS loss of €0.05, setting a cautious tone for how you might think about the latest numbers. Over the previous two halves in 2024, the company saw revenue move from €916.1 million in the first half to €944.4 million in the second half, while basic EPS shifted from €0.12 to €0.14, giving you a clear view of how the current setback compares to more recent profitability. With...
ENXTBR:MONT
ENXTBR:MONTIndustrial REITs

Montea Comm. VA (ENXTBR:MONT) Revenue Gain Tests Bullish Narratives On Earnings Quality

Montea Comm. VA (ENXTBR:MONT) has put fresh numbers on the table for FY 2025, with Q4 revenue of €56.5 million and basic EPS of €2.09, alongside trailing twelve month revenue of €167.1 million and EPS of €7.09. The company has seen quarterly revenue move from €47.5 million in Q4 2024 to €56.5 million in Q4 2025, while basic EPS shifted from €2.17 to €2.09 over the same period. This sets up a results season in which investors are weighing income appeal and reported earnings power against how...
ENXTBR:NEXTA
ENXTBR:NEXTAREITs

Nextensa (ENXTBR:NEXTA) Return To Profit In H1 2025 Tests Long Term Bearish Narratives

Nextensa (ENXTBR:NEXTA) has put fresh numbers on the table for FY 2025, with first half revenue of €50.7m and basic EPS of €1.96, setting a clear marker for how the year is tracking so far. The company has seen revenue move from €65.1m in the first half of 2024 to €59.9m in the second half and then to €50.7m in the first half of 2025, while EPS shifted from €1.39 to an EPS loss of €2.48 and then back to EPS of €1.96. This gives investors a clear view of how the income line has been...